September 12, 2016 / 12:06 PM / 3 years ago

BRIEF-Takeda and Macrogenics announce conclusion of MGD010 license and option agreement

Sept 12 (Reuters) - MacroGenics, Inc. :

* Takeda and Macrogenics announce the conclusion of their MGD010 license and option agreement

* MacroGenics inc says has regained worldwide rights to MGD010, a bispecific molecule targeting CD32B and CD79B

* Macrogenics inc says Takeda’s decision comes earlier than predefined expiration of its option exercise period Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below